Aug 17 (Reuters) - PYC Therapeutics Ltd (PYC) :
- PYC THERAPEUTICS ASSEMBLES OPHTHALMOLOGY-FOCUSED CLINICAL ADVISORY BOARD
- PYC THERAPEUTICS - CLINICAL ADVISORY BOARD WILL INITIALLY FOCUS ON VP-001 FOR TREATMENT OF RETINITIS PIGMENTOSA TYPE 11
- PYC THERAPEUTICS - FOR VP-001, EXPECTS LARGER ANIMAL DATA READOUTS IN 2H 2021, INVESTIGATIONAL NEW DRUG FILING IN MID-2022
News: PYC PYC Therapeutics Forms Ophthalmology-Focused Clinical Advisory Board
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.020(1.77%) |
Mkt cap ! $670.7M | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.18 | $1.11 | $172.3K | 151.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 592 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 4211 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |